Brief: Talis Biomedical Reports Fourth Quarter Revenue Of $900,000
15/03/2022 20:48
March 15 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS BIOMEDICAL PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* Q4 REVENUE $900,000
* UNDERTAKING AN ABOUT 25% REDUCTION IN WORKFORCE,
IMPLEMENTING
ADDITIONAL COST MEASURES TO ALIGN RESOURCES, EXTEND CASH RUNWAY
* TALIS - WORKFORCE REDUCTION EXPECTED TO RESULT IN
ANNUALIZED
OPERATING EXPENSE SAVINGS OF $10 MILLION IN COMPENSATION
EXPENSES, $26 MILLION IN OTHER EXPENSES
Source text for Eikon: ID:nGNX6xHyPC
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash